Dr. Abbott is an Associate Professor and Executive Director of the Center for Oncology Research at Arkansas Colleges of Health Education (ACHE). The Center for Oncology Research is located in the new Research Institute and Health Wellness Center at ACHE. The Research Institute will house over 100,000 sq. ft. of laboratory research space with an expansive vivarium and animal imaging facilities along with the latest microscopy, flow cytometry, metabolomics, and mass spectrometry equipment. Dr. Abbott has been a leader in the field of glycoproteomics and biomarker discovery for over 15 years. Dr. Abbott received her PhD in Biochemistry at The University of Georgia in 2004. She was awarded an American Cancer Society Postdoctoral Fellowship in 2005 where she developed lectin capture methods for the analysis of glycoproteins from human tissues and plasma using mass spectrometry methods. She has been funded for ovarian and breast cancer research since 2010. She was awarded the competitive National Cancer Institute Alliance of Glycobiologists grant to understand how complex carbohydrates contribute to the development and progression of ovarian cancer. She has also been funded by the NCI Innovative Molecular Analysis Technologies program that supports the development of novel and transformative technologies to detect and treat human cancers. Dr. Abbott’s research is currently focused in three main areas: the development of innovative therapeutics for cancer, studies on the roles of tumor-specific glycans in ovarian cancer progression, and technology development for the mass spectrometry identification of lipid linked membrane proteins.

Education

• BS from Georgia College and State University and PhD in Biochemistry from the University of Georgia
• Postdoctoral fellowship at the Complex Carbohydrate Research Center at the University of Georgia



Accomplishments

• American Cancer Society Postdoctoral Fellowship Award in 2005



Areas of Expertise/Interest

• Novel cancer therapeutics and biomarkers with an emphasis on the roles of glycans and glycoproteins in cancer progression